Previous 10 | Next 10 |
home / stock / dva / dva articles
BrainsWay Ltd. (NASDAQ: BWAY) recently signed an exclusive multi-year distribution agreement with a specialty distributor serving both the acute ho...
In a market dealing with external shocks, value investing, or the strategy of putting money in underappreciated stocks, is fast gaining popularity....
DaVita (NYSE: DVA) recently extended the pilot phase of a previously announced supply and collaboration agreement with Nuwellis (NASDAQ: NUWE)...
Investors demanded more clarity from German healthcare group Fresenius SE regarding its intentions to relinquish strategic control over d...
Disclosed on May 14, BARBARA DESOER, Director at DaVita (NYSE:DVA), executed a substantial insider sell as per the latest SEC filing. What Happened...
Koninklijke Philips (NYSE: PHG) recently announced the receipt of FDA 510(k) approval for its Zenition 30 mobile C-arm. The approval is likely to m...
Philips (NYSE: PHG) is leaving no stone unturned to bolster its patient monitoring solutions portfolio on the back of recent collaborations. In thi...
After wrapping up a robust first quarter on strong corporate profits, enthusiasm around AI and hopes that the Fed will cut rates, Wall Street's...
Globus Medical (NYSE: GMED) continues to gain from surging demand for its Musculoskeletal Solutions products. Meanwhile, the company is expanding i...
News, Short Squeeze, Breakout and More Instantly...
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call PR Newswire DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, Aug...
2024-06-21 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...